HAWP.F Stock Overview
Manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Haw Par Corporation Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$8.35 |
52 Week High | S$8.35 |
52 Week Low | S$7.03 |
Beta | 0.37 |
11 Month Change | 3.73% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -3.67% |
5 Year Change | -12.11% |
Change since IPO | 247.92% |
Recent News & Updates
Recent updates
Shareholder Returns
HAWP.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 4.2% | 2.0% |
1Y | n/a | 13.7% | 32.4% |
Return vs Industry: Insufficient data to determine how HAWP.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how HAWP.F performed against the US Market.
Price Volatility
HAWP.F volatility | |
---|---|
HAWP.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.9% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HAWP.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine HAWP.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1969 | n/a | Ee Lim Wee | www.hawpar.com |
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities.
Haw Par Corporation Limited Fundamentals Summary
HAWP.F fundamental statistics | |
---|---|
Market cap | US$1.85b |
Earnings (TTM) | US$174.02m |
Revenue (TTM) | US$177.46m |
10.6x
P/E Ratio10.4x
P/S RatioIs HAWP.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HAWP.F income statement (TTM) | |
---|---|
Revenue | S$239.06m |
Cost of Revenue | S$102.66m |
Gross Profit | S$136.40m |
Other Expenses | -S$98.03m |
Earnings | S$234.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.06 |
Gross Margin | 57.06% |
Net Profit Margin | 98.06% |
Debt/Equity Ratio | 1.0% |
How did HAWP.F perform over the long term?
See historical performance and comparison